Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Total Current Liabilities (2016 - 2026)

Apyx Medical filings provide 16 years of Total Current Liabilities readings, the most recent being $11.7 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 9.13% to $11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 million, a 9.13% increase, with the full-year FY2025 number at $11.7 million, up 9.13% from a year prior.
  • Total Current Liabilities hit $11.7 million in Q4 2025 for Apyx Medical, up from $11.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $19.0 million in Q2 2023 to a low of $9.5 million in Q1 2025.
  • Median Total Current Liabilities over the past 5 years was $11.1 million (2022), compared with a mean of $11.8 million.
  • Biggest five-year swings in Total Current Liabilities: soared 67.63% in 2023 and later crashed 44.09% in 2024.
  • Apyx Medical's Total Current Liabilities stood at $13.2 million in 2021, then fell by 10.26% to $11.8 million in 2022, then rose by 7.51% to $12.7 million in 2023, then dropped by 15.85% to $10.7 million in 2024, then rose by 9.13% to $11.7 million in 2025.
  • The last three reported values for Total Current Liabilities were $11.7 million (Q4 2025), $11.0 million (Q3 2025), and $10.6 million (Q2 2025) per Business Quant data.